{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:35:22Z","timestamp":1791066922460,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.mad.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T18:45:54Z","timestamp":1314038754000},"page":"443-448","source":"Crossref","is-referenced-by-count":118,"title":["Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain"],"prefix":"10.1016","volume":"132","author":[{"given":"Mark A.","family":"Lovell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sony","family":"Soman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2011.08.003_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nbd.2010.04.011","article-title":"Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics","volume":"39","author":"Aluise","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mad.2011.08.003_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0092-8674(95)90326-7","article-title":"Degradation of mRNA in eukaryotes","volume":"81","author":"Beelman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mad.2011.08.003_bib0015","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","article-title":"Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease","volume":"48","author":"Bradley","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2011.08.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.08.016","article-title":"Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression","author":"Bradley","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2011.08.003_bib0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11064-006-9071-5","article-title":"Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease","volume":"31","author":"Ding","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.mad.2011.08.003_bib0035","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1523\/JNEUROSCI.3040-05.2005","article-title":"Ribosome dysfunction is an early event in Alzheimer's disease","volume":"25","author":"Ding","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2011.08.003_bib0040","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1046\/j.1432-1033.2002.03260.x","article-title":"DNA and RNA damage by Cu(II)-amikacin complex","volume":"269","author":"Jezowska-Bojczuk","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mad.2011.08.003_bib0045","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1093\/nar\/gkm821","article-title":"Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease","volume":"35","author":"Lovell","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mad.2011.08.003_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2007.07.030","article-title":"Oxidatively modified RNA in mild cognitive impairment","volume":"29","author":"Lovell","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mad.2011.08.003_bib0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-8993(99)02335-5","article-title":"Decreased base excision repair and increased helicase activity in Alzheimer's disease brain","volume":"855","author":"Lovell","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.mad.2011.08.003_bib0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0197-4580(00)00235-9","article-title":"Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures","volume":"22","author":"Lovell","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2011.08.003_bib0065","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/nar\/gkm189","article-title":"Identification and characterization of OGG1 mutations in patients with Alzheimer's disease","volume":"35","author":"Mao","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mad.2011.08.003_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","article-title":"Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease","volume":"19","author":"Markesbery","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2011.08.003_bib0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.20629","article-title":"Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment","volume":"58","author":"Markesbery","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mad.2011.08.003_bib0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2362.2004.01343.x","article-title":"Reactive oxygen species induce RNA damage in human atherosclerosis","volume":"34","author":"Martinet","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.mad.2011.08.003_bib0085","first-page":"385","article-title":"Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde","volume":"94","author":"McGarth","year":"2001","journal-title":"Q. J. Med."},{"key":"10.1016\/j.mad.2011.08.003_bib0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.410360510","article-title":"Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease","volume":"36","author":"Mecocci","year":"1994","journal-title":"Am. Neurol. Assoc."},{"key":"10.1016\/j.mad.2011.08.003_bib0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0955-0674(00)00214-3","article-title":"mRNA turnover","volume":"13","author":"Mitchell","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mad.2011.08.003_bib0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1749-6632.1999.tb07855.x","article-title":"Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome","volume":"893","author":"Nunomura","year":"1999","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.mad.2011.08.003_bib0105","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00001756-200211150-00009","article-title":"Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies","volume":"13","author":"Nunomura","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.mad.2011.08.003_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2004.06.003","article-title":"Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease","volume":"17","author":"Nunomura","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mad.2011.08.003_bib0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mad.2011.08.003_bib0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0002-9440(10)63968-5","article-title":"Brain regional quantification of F-ring and D-\/E-ring isoprostanes and neuroprostanes in Alzheimer's disease","volume":"158","author":"Reich","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mad.2011.08.003_bib0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00777516","article-title":"30S ribosomal proteins cross-linked to 16S RNA by periodate oxidation followed by borohydride reduction","volume":"4","author":"Rinke","year":"1978","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.mad.2011.08.003_bib0130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neurobiolaging.2005.03.022","article-title":"Quantification of oxidized RNAs in Alzheimer's disease","volume":"27","author":"Shan","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2011.08.003_bib0135","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1523\/JNEUROSCI.23-12-04913.2003","article-title":"The identification and characterization of oxidized RNAs in Alzheimer's disease","volume":"23","author":"Shan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mad.2011.08.003_bib0140","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.freeradbiomed.2008.06.003","article-title":"Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain","volume":"45","author":"Shao","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mad.2011.08.003_bib0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jphotobiol.2004.08.009","article-title":"DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines","volume":"77","author":"Singh","year":"2004","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.mad.2011.08.003_bib0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2010-1222","article-title":"Role of oxidative stress in the progression of Alzheimer's disease","volume":"19","author":"Sultana","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mad.2011.08.003_bib0155","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1089\/ars.2006.8.2021","article-title":"Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics","volume":"8","author":"Sultana","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mad.2011.08.003_bib0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.biochem.69.1.571","article-title":"Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae","volume":"69","author":"Tucker","year":"2000","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.mad.2011.08.003_bib0165","first-page":"7","article-title":"The exosome: a proteasome for RNA?","volume":"3","author":"van Hoof","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mad.2011.08.003_bib0170","doi-asserted-by":"crossref","first-page":"R285","DOI":"10.1016\/S0960-9822(02)00802-3","article-title":"Messenger RNA degradation: beginning at the end","volume":"12","author":"van Hoof","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mad.2011.08.003_bib0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1471-4159.2005.03615.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment","volume":"96","author":"Wang","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mad.2011.08.003_bib0185","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/nar\/gkm605","article-title":"Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment","volume":"35","author":"Weissman","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mad.2011.08.003_bib0190","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","article-title":"Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease","volume":"27","author":"Williams","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2011.08.003_bib0195","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","article-title":"Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons","volume":"154","author":"Zhang","year":"1999","journal-title":"Am. J. Pathol."}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637411001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637411001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T07:19:13Z","timestamp":1560496753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637411001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":37,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0047637411001229"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2011.08.003","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}